Literature DB >> 17172567

PINK1 mutation heterozygosity and the risk of Parkinson's disease.

M Toft1, R Myhre, L Pielsticker, L R White, J O Aasly, M J Farrer.   

Abstract

BACKGROUND: Mutations in the PTEN-induced kinase 1 (PINK1) gene have been identified in recessively inherited and sporadic early-onset parkinsonism (EOP).
METHODS: A total of 131 Norwegian patients diagnosed with Parkinson's disease were included. Of them, 89 participants had EOP (onset < or = 50 years); the remaining had familial late-onset disease (mean age at onset 64 years). PINK1 analysis included sequencing and gene dose assessment. Mutations were examined in 350 controls.
RESULTS: Heterozygous missense mutations in PINK1 were found in 3 of 131 patients; none of the patients carried homozygous or compound heterozygous mutations. One of these three patients had a father affected by Parkinson's disease, and he carried the mutation. Three new and seven known polymorphic variants were identified, although none seemed to be associated with disease risk.
CONCLUSIONS: PINK1 mutations are rare in Norwegian patients with EOP and familial Parkinson's disease. However, the data suggest that some heterozygous mutations might increase the risk of developing Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172567      PMCID: PMC2117782          DOI: 10.1136/jnnp.2006.097840

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.

Authors:  Ekaterina Rogaeva; Janel Johnson; Anthony E Lang; Cindy Gulick; Katrina Gwinn-Hardy; Toshitaka Kawarai; Christine Sato; Angharad Morgan; John Werner; Robert Nussbaum; Agnes Petit; Michael S Okun; Aideen McInerney; Ronald Mandel; Justus L Groen; Hubert H Fernandez; Ron Postuma; Kelly D Foote; Shabnam Salehi-Rad; Yan Liang; Sharon Reimsnider; Anurag Tandon; John Hardy; Peter St George-Hyslop; Andrew B Singleton
Journal:  Arch Neurol       Date:  2004-12

2.  Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism.

Authors:  Y Li; H Tomiyama; K Sato; Y Hatano; H Yoshino; M Atsumi; M Kitaguchi; S Sasaki; S Kawaguchi; H Miyajima; T Toda; Y Mizuno; N Hattori
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

3.  PINK1 (PARK6) associated Parkinson disease in Ireland.

Authors:  D G Healy; P M Abou-Sleiman; J M Gibson; O A Ross; S Jain; S Gandhi; D Gosal; M M K Muqit; N W Wood; T Lynch
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

4.  PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.

Authors:  Christine Klein; Ana Djarmati; Katja Hedrich; Nora Schäfer; Cesa Scaglione; Roberta Marchese; Norman Kock; Birgitt Schüle; Anja Hiller; Thora Lohnau; Susen Winkler; Karin Wiegers; Robert Hering; Peter Bauer; Olaf Riess; Giovanni Abbruzzese; Paolo Martinelli; Peter P Pramstaller
Journal:  Eur J Hum Genet       Date:  2005-09       Impact factor: 4.246

5.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.

Authors:  Jeehye Park; Sung Bae Lee; Sungkyu Lee; Yongsung Kim; Saera Song; Sunhong Kim; Eunkyung Bae; Jaeseob Kim; Minho Shong; Jin-Man Kim; Jongkyeong Chung
Journal:  Nature       Date:  2006-05-03       Impact factor: 49.962

6.  Clinical features of LRRK2-associated Parkinson's disease in central Norway.

Authors:  Jan O Aasly; Mathias Toft; Ignacio Fernandez-Mata; Jennifer Kachergus; Mary Hulihan; Linda R White; Matthew Farrer
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

7.  Novel PINK1 mutations in early-onset parkinsonism.

Authors:  Yasuko Hatano; Yuanzhe Li; Kenichi Sato; Shuichi Asakawa; Yasuhiro Yamamura; Hiroyuki Tomiyama; Hiroyo Yoshino; Masato Asahina; Susumu Kobayashi; Sharon Hassin-Baer; Chin-Song Lu; Arlene R Ng; Raymond L Rosales; Nobuyoshi Shimizu; Tatsushi Toda; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

8.  Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism.

Authors:  Christan F Rohé; Pasquale Montagna; Guido Breedveld; Pietro Cortelli; Ben A Oostra; Vincenzo Bonifati
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

Review 9.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

10.  Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Authors:  Enza Maria Valente; Patrick M Abou-Sleiman; Viviana Caputo; Miratul M K Muqit; Kirsten Harvey; Suzana Gispert; Zeeshan Ali; Domenico Del Turco; Anna Rita Bentivoglio; Daniel G Healy; Alberto Albanese; Robert Nussbaum; Rafael González-Maldonado; Thomas Deller; Sergio Salvi; Pietro Cortelli; William P Gilks; David S Latchman; Robert J Harvey; Bruno Dallapiccola; Georg Auburger; Nicholas W Wood
Journal:  Science       Date:  2004-04-15       Impact factor: 47.728

View more
  17 in total

Review 1.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

2.  Ordered-subset analysis (OSA) for family-based association mapping of complex traits.

Authors:  Ren-Hua Chung; Silke Schmidt; Eden R Martin; Elizabeth R Hauser
Journal:  Genet Epidemiol       Date:  2008-11       Impact factor: 2.135

3.  Variation in the PTEN-induced putative kinase 1 gene associated with the increase risk of type 2 diabetes in northern Chinese.

Authors:  Yanchun Qu; Liang Sun; Ze Yang; Ruifa Han
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

4.  Differential submitochondrial localization of PINK1 as a molecular switch for mediating distinct mitochondrial signaling pathways.

Authors:  Dana Fallaize; Lih-Shen Chin; Lian Li
Journal:  Cell Signal       Date:  2015-10-06       Impact factor: 4.315

Review 5.  The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity.

Authors:  David N Hauser; Christopher T Primiani; Mark R Cookson
Journal:  Curr Protein Pept Sci       Date:  2017       Impact factor: 3.272

6.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.

Authors:  L N Clark; B M Ross; Y Wang; H Mejia-Santana; J Harris; E D Louis; L J Cote; H Andrews; S Fahn; C Waters; B Ford; S Frucht; R Ottman; K Marder
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

7.  Comprehensive assessment of PINK1 variants in Parkinson's disease.

Authors:  Lynne Krohn; Francis P Grenn; Mary B Makarious; Jonggeol Jeffrey Kim; Sara Bandres-Ciga; Dorien A Roosen; Ziv Gan-Or; Mike A Nalls; Andrew B Singleton; Cornelis Blauwendraat
Journal:  Neurobiol Aging       Date:  2020-03-10       Impact factor: 4.673

Review 8.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

9.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

10.  Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.

Authors:  Ronny Myhre; Stina Steinkjer; Alice Stormyr; Gina L Nilsen; Hiba Abu Zayyad; Khalid Horany; Mohamad K Nusier; Helge Klungland
Journal:  BMC Neurol       Date:  2008-12-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.